Your browser doesn't support javascript.
loading
New papulovesicular rash in the course of COVID-19 signaling viral reactivation.
Rihl, Marcos Frata; Fendt, Lúcia Costa Cabral; Nedel, Wagner Luis.
Affiliation
  • Rihl MF; Hospital de Clínicas de Porto Alegre, Intensive Care Unit - Porto Alegre (RS), Brazil.
  • Fendt LCC; Hospital de Clínicas de Porto Alegre, Intensive Care Unit - Porto Alegre (RS), Brazil.
  • Nedel WL; Hospitalar Conceição, Intensive Care Unit - Porto Alegre (RS), Brazil.
Rev Assoc Med Bras (1992) ; 67(2): 182-184, 2021 Feb.
Article in En | MEDLINE | ID: mdl-34406241
ABSTRACT
Cutaneous manifestations are considered an infrequent presentation of coronavirus disease 2019 (COVID-19) and are mostly described in outpatient settings. Its onset during the course of the severe COVID-19 disease has been poorly described in severe cases. Studies focused on dermatological manifestations mostly described maculopapular or pernio-like lesions and less frequently vesicular or varicella-like eruption. We described the occurrence of a vesiculopapular eruption in three laboratory-confirmed COVID-19 patients associated with severe lung injury in whom the skin findings preceded viral reactivation and recrudescence of hypoxemia. The potential mechanisms for COVID-19-related cutaneous manifestations include immune hypersensitivity, cytokine-release syndrome, deposition of microthrombi, and vasculitis.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Exanthema / COVID-19 Type of study: Etiology_studies Limits: Humans Language: En Journal: Rev Assoc Med Bras (1992) Year: 2021 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Exanthema / COVID-19 Type of study: Etiology_studies Limits: Humans Language: En Journal: Rev Assoc Med Bras (1992) Year: 2021 Document type: Article Affiliation country: